Literature DB >> 8256859

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

R Moll1, M Mitze, U H Frixen, W Birchmeier.   

Abstract

The epithelial-specific cell-cell adhesion molecule E-cadherin was analyzed immunohistochemically on tissue sections of 89 human primary infiltrating breast carcinomas, using monoclonal antibodies 6F9 (for cryostat sections) and 5H9 (for cryostat and paraffin sections). The tumors included 41 well and moderately differentiated infiltrating ductal carcinomas (IDCs) most of which (78%) showed strong linear staining at the cell borders at a level, as high as luminal cells of normal mammary glands. The 26 poorly differentiated, more highly malignant IDCs examined also were all positive for E-cadherin, although a higher proportion of them (54%) showed reduced staining, which was heterogeneous and dotted over the cell borders. In contrast, 19 of 22 infiltrating lobular carcinomas (ILCs), which were either of the dispersed (classical), solid, or the mixed type, did not express E-cadherin, whereas three cases showed weak staining. In situ lesions of ILCs and pure lobular carcinoma in situ (four cases) were all E-cadherin negative, whereas intraductal carcinomas (11 cases) exhibited mostly strong staining. The results were confirmed by Western blotting. The data indicate that loss of E-cadherin expression is an early event in the formation of the lobular type of breast carcinomas. The absence of E-cadherin signifies a partial loss of epithelial differentiation and may account for the extended spread of lobular carcinoma in situ and the peculiar diffuse invasion mode of ILC. The generation of dedifferentiated IDCs can only in part be correlated with reduced expression of the intercellular adhesion molecule E-cadherin. Other factors are obviously also involved during invasion of this carcinoma type.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256859      PMCID: PMC1887260     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  41 in total

1.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role.

Authors:  K Vleminckx; L Vakaet; M Mareel; W Fiers; F van Roy
Journal:  Cell       Date:  1991-07-12       Impact factor: 41.582

2.  The E-cadherin promoter: functional analysis of a G.C-rich region and an epithelial cell-specific palindromic regulatory element.

Authors:  J Behrens; O Löwrick; L Klein-Hitpass; W Birchmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

3.  E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor dedifferentiation and lymph node metastasis.

Authors:  J H Schipper; U H Frixen; J Behrens; A Unger; K Jahnke; W Birchmeier
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

4.  Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.

Authors:  A Leone; U Flatow; C R King; M A Sandeen; I M Margulies; L A Liotta; P S Steeg
Journal:  Cell       Date:  1991-04-05       Impact factor: 41.582

5.  Expression of E- and P-cadherin in gastric carcinomas.

Authors:  Y Shimoyama; S Hirohashi
Journal:  Cancer Res       Date:  1991-04-15       Impact factor: 12.701

6.  Expression of immunoreactive E-cadherin adhesion molecules in human cancers.

Authors:  H Shiozaki; H Tahara; H Oka; M Miyata; K Kobayashi; S Tamura; K Iihara; Y Doki; S Hirano; M Takeichi
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

7.  Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential.

Authors:  J Jouanneau; J Gavrilovic; D Caruelle; M Jaye; G Moens; J P Caruelle; J P Thiery
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

8.  Allelic loss of chromosomes 16q and 10q in human prostate cancer.

Authors:  B S Carter; C M Ewing; W S Ward; B F Treiger; T W Aalders; J A Schalken; J I Epstein; W B Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  Expression of the antimetastatic gene nm23 in human breast cancer: an association with good prognosis.

Authors:  C Hennessy; J A Henry; F E May; B R Westley; B Angus; T W Lennard
Journal:  J Natl Cancer Inst       Date:  1991-02-20       Impact factor: 13.506

10.  Evidence for the identity of human scatter factor and human hepatocyte growth factor.

Authors:  K M Weidner; N Arakaki; G Hartmann; J Vandekerckhove; S Weingart; H Rieder; C Fonatsch; H Tsubouchi; T Hishida; Y Daikuhara
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

View more
  116 in total

Review 1.  Cadherin junctions in mammary tumors.

Authors:  M J Wheelock; A P Soler; K A Knudsen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-07       Impact factor: 2.673

2.  DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells.

Authors:  Yingming Jiang; Tao Wan; Guoyou Chen; Fangming Xiu; Dajing Xia; Weiping Zhang; Xiangyang Zhou; Xuetao Cao
Journal:  J Cancer Res Clin Oncol       Date:  2003-02-12       Impact factor: 4.553

3.  E-cadherin immunohistochemical expression in invasive lobular carcinoma of the breast: correlation with morphology and CDH1 somatic alterations.

Authors:  Anne Grabenstetter; Abhinita S Mohanty; Satshil Rana; Ahmet Zehir; A Rose Brannon; Timothy M D'Alfonso; Deborah F DeLair; Lee K Tan; Dara S Ross
Journal:  Hum Pathol       Date:  2020-06-26       Impact factor: 3.466

4.  Soluble E-cadherin is a valid prognostic marker in gastric carcinoma.

Authors:  A O Chan; S K Lam; K M Chu; C M Lam; E Kwok; S Y Leung; S T Yuen; S Y Law; W M Hui; K C Lai; C Y Wong; H C Hu; C L Lai; J Wong
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

5.  Loss of E-cadherin expression associated with lymph node metastases in small breast carcinomas.

Authors:  N C Hunt; A G Douglas-Jones; B Jasani; J M Morgan; M Pignatelli
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

Review 6.  Alpha-catenin: at the junction of intercellular adhesion and actin dynamics.

Authors:  Agnieszka Kobielak; Elaine Fuchs
Journal:  Nat Rev Mol Cell Biol       Date:  2004-08       Impact factor: 94.444

Review 7.  Snail family regulation and epithelial mesenchymal transitions in breast cancer progression.

Authors:  Antonio Garcia de Herreros; Sandra Peiró; Mayssaa Nassour; Pierre Savagner
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-09       Impact factor: 2.673

8.  Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth.

Authors:  Annette Lebeau; Claudia Müller-Aufdemkamp; Clarissa Allmacher; Ulrich Sauer; Andreas Nerlich; Ralf Lichtinghagen; Udo Löhrs
Journal:  J Mol Histol       Date:  2004-06       Impact factor: 2.611

9.  Elevated expression of E-cadherin in primary breast cancer and its corresponding metastatic lymph node.

Authors:  Lin Chen; Wei Jian; Leisheng Lu; Lijun Zheng; Zhen Yu; Donglei Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

10.  Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.

Authors:  Kiyomi O Toyooka; Shinichi Toyooka; Anirban Maitra; Qinghua Feng; Nancy C Kiviat; Alice Smith; John D Minna; Raheela Ashfaq; Adi F Gazdar
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.